Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Neoplasms 3Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Endometrial Neoplasms 2Uterine Neoplasms 1Sarcoma 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 4Pemetrexed 3Paclitaxel 3Fulvestrant 2FANG vaccine 2Drug Therapy 2Carboplatin 2tucatinib 1trastuzumab deruxtecan 1seribantumab 1selinexor 1osimertinib 1gedatolisib 1dactolisib 1cobimetinib 1cemiplimab 1atezolizumab 1Watchful Waiting 1Trastuzumab 1Transurethral Resection of Prostate 1Trabectedin 1Therapeutics 1Sutures 1Radiation 1Quality of Life 1Pregnancy Tests 1Patient Reported Outcome Measures 1Oxaliplatin 1OSI 930 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Neoplasms × Brachytherapy × Clear all
NCT01045187 2012-08-01

Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer

Xoft, Inc.

Phase NA Completed
15 enrolled 5 charts
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡